Revolutionizing Crypto Trading: Binance Now Offers Off-Exchange Custody for Trading Collateral as Market Share Rebounds

Binance Allows Customers to Custody Trading Collateral Off Exchange as Market Share Recovers Introduction A Binance representative confirmed in a Jan. 30 email statement sent to CryptoSlate that the platform is now allowing institutional investors to secure their trading collateral through a third-party banking partner. Binance’s solution, described as a “banking triparty” arrangement, has been…

Read More

Granite Ridge Resources: Tale of the Tape – Outperforming Earnings Expectations: Is It Time to Invest?

Granite Ridge Resources, Inc. (GRNT): A Delightful Dance of Ingredients for an Earnings Beat Granite Ridge Resources, Inc. (GRNT), a leading player in the natural gas industry, is gearing up to release its latest earnings report. The anticipation in the air is palpable, as investors and analysts alike are eagerly awaiting the results. But what…

Read More

TransMedics Group (TMDX) Sued for Alleged Fraud and Safety Lapses: Class Action Lawsuit Filed by Hagens Berman

Class-Action Lawsuit Filed Against TransMedics Group, Inc.: Allegations of Fraudulent Practices and Concealed Safety Issues On March 10, 2025, a significant legal development unfolded in the medical technology industry. A class-action lawsuit was filed against TransMedics Group, Inc. (TMDX), a leading medical technology company specializing in organ transplant therapy. The lawsuit, identified as Jewik v….

Read More

Charmingly Eccentric: Bausch Health and Salix to Present at AASLD on Revolutionary Cirrhosis Treatment

Charmingly Eccentric Next Generation Product: A Game Changer in Gastrointestinal Health Exciting News in Gastroenterology LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals (“Salix”), today announced the first look at its late-stage RED-C clinical trial program. The program will be presented at…

Read More

Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart in Type 1 Diabetes Patients Undergoing Islet Transplantation

Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart Breakthrough in Type 1 Diabetes Patients Undergoing Islet Transplantation Diabetes has been a prevalent health issue affecting millions of people worldwide, with Type 1 Diabetes (T1D) being a particularly challenging condition to manage. However, a recent development by Eledon Pharmaceuticals has sparked hope and excitement…

Read More